Nuveen’s third-annual EQuilibrium study surveyed 800 global institutional investors, including nearly 200 insurance companies, to uncover new insights into how they expect to achieve their investment objectives. Strategic and tactical asset allocations are evolving, credit and duration continue to be in favor, and impact investing with balance sheet assets is here to stay.
